Similar articles

• Studies with ascites tumors in experimental chemotherapy. I. Properties of six selected ascites tumors.

  SASSENRATH EN, COSTA FM, GREENBERG DM. SASSENRATH EN, et al. Cancer Chemother Rep. 1961 Apr;11:5-12. Cancer Chemother Rep. 1961. PMID: 13746674 No abstract available.
• Evaluation of chemotherapeutic agents against a variety of mouse ascites tumors. III.

  RUTMAN RJ, LEWIS FS, BUCKNER S, PRICE CC, LLEWELLYN F, OWEN E. RUTMAN RJ, et al. Cancer Res. 1962 Aug;22:559-608. Cancer Res. 1962. PMID: 14495504 No abstract available.
• Mechanism of natural and acquired resistance to methyl-bis(2-chloroethyl)amine N-oxide in ascites tumors. I. Permeability of tumor cells to alkylating agents.

  HIRONO I, KACHI H, OHASHI A. HIRONO I, et al. Gan. 1962 Mar;53:73-80. Gan. 1962. PMID: 13907657 No abstract available.
• TREATMENT OF EXPERIMENTAL ASCITES TUMORS WITH CRYSTALLINE RIBONUCLEASE.

  PODOLSKY S, WASE A, CARDENAS J. PODOLSKY S, et al. Curr Ther Res Clin Exp. 1964 May;6:387-93. Curr Ther Res Clin Exp. 1964. PMID: 14193773 No abstract available.
• Combined action of 5-fluorouracil and other cytotoxic agents with crystalline ribonuclease on mouse ascites tumor.

  PODOLSKY S, WASE AW, CARDENAS J. PODOLSKY S, et al. Henry Ford Hosp Med Bull. 1961 Dec;9:583-94. Henry Ford Hosp Med Bull. 1961. PMID: 14487340 No abstract available.